The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The J-Curve Phenomenon in Hypertension
Open accessAbstract
Almost immediately after antihypertensive therapy was proven effective in preventing cardiovascular events, the J-curve issue emerged as a hot topic. The Hypertension Optimal Treatment (HOT) trial attempted to address this question (diastolic blood pressure <80, <85, and <90 mm Hg) but ended up with a post hoc analysis indicating a nadir of 138.5 mm Hg systolic and 82.6 mm Hg diastolic blood pressure. Nevertheless, this observational finding was supported by the results of observational studies in the general population and by post hoc analyses of antihypertensive treatment trials. The currently ongoing Systolic Hypertension Optimal Treatment (SHOT) trial investigates whether the relationship between systolic blood pressure and stroke recurrence is linear or J-shaped by treating systolic blood pressure to <125, <135, and <145 mm Hg in patients with a history of recent stroke. This trial may provide additional but probably inconclusive evidence, because optimal blood pressure might differ between individuals and across outcomes. Nevertheless, a universal beneficial, instead of optimal, level of blood pressure for antihypertensive treatment may exist approximating 130/80 mm Hg and should be investigated by comparing 130/80 mm Hg with 140/90 mm Hg as a target blood pressure in hypertensive patients with the simultaneous use of modern blood pressure measuring techniques, such as home and ambulatory blood pressure monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
Anderson, C. S., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214609 · Cited by 1,614
Self-citationKinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
(1967) · JAMA · doi:10.1001/jama.202.11.1028 · Cited by 1,298
Pepine, C. J., Handberg, E. M., Cooper-DeHoff, R. M., Marks, R. G., Kowey, P., Messerli, F. H., Mancia, G., Cangiano, J. L., Garcia-Barreto, D., Keltai, M., et al. (2003) · JAMA · doi:10.1001/jama.290.21.2805 · Cited by 1,286
O’Rourke, M. F., & Safar, M. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000168052.00426.65 · Cited by 1,279
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
(2014) · Hypertension Research · doi:10.1038/hr.2014.20 · Cited by 1,049
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Messerli, F. H., Mancia, G., Conti, C. R., Hewkin, A. C., Kupfer, S., Champion, A., Kolloch, R., Benetos, A., & Pepine, C. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00005 · Cited by 779
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
Buse, J. B. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.003 · Cited by 661
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE
Cruickshank, J., Thorp, J., & Zacharias, F. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90231-5 · Cited by 656
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
(2016) · New England Journal of Medicine · doi:10.1056/nejmc1602668 · Cited by 654
Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. L., & Pepine, C. J. (2010) · JAMA · doi:10.1001/jama.2010.884 · Cited by 651
(1970) · JAMA · doi:10.1001/jama.213.7.1143 · Cited by 554
JATOS Study Group (2008) · Hypertension Research · doi:10.1291/hypres.31.2115 · Cited by 397
Ogihara, T., Saruta, T., Rakugi, H., Matsuoka, H., Shimamoto, K., Shimada, K., Imai, Y., Kikuchi, K., Ito, S., Eto, T., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146035 · Cited by 371
Bangalore, S., Messerli, F. H., Wun, C.-C., Zuckerman, A. L., DeMicco, D., Kostis, J. B., LaRosa, J. C., & for the Treating to New Targets Steering Committee and Investigators (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq328 · Cited by 367
Sleight, P., Redon, J., Verdecchia, P., Mancia, G., Gao, P., Fagard, R., Schumacher, H., Weber, M., Böhm, M., Williams, B., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832d7370 · Cited by 352
Boutitie, F., Gueyffier, F., Pocock, S., Fagard, R., Boissel, J. P., & for the INDANA Project Steering Committee (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00007 · Cited by 287
Low blood pressure and dementia in elderly people: the Kungsholmen project
Guo, Z., Viitanen, M., Fratiglioni, L., & Winblad, B. (1996) · BMJ · doi:10.1136/bmj.312.7034.805 · Cited by 280
Manning, L., Hirakawa, Y., Arima, H., Wang, X., Chalmers, J., Wang, J., Lindley, R., Heeley, E., Delcourt, C., Neal, B., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70018-3 · Cited by 273
Self-citationWITTEMAN, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91459-1 · Cited by 264
Stewart, I. M. G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91274-1 · Cited by 245
D'Agostino, R. B., Belanger, A. J., Kannel, W. B., & Cruickshank, J. M. (1991) · BMJ · doi:10.1136/bmj.303.6799.385 · Cited by 239
The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
(2014) · Hypertension Research · doi:10.1038/hr.2014.3 · Cited by 235
Blood pressure regulation IX: cerebral autoregulation under blood pressure challenges
Tzeng, Y.-C., & Ainslie, P. N. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2667-y · Cited by 231
Rothwell, P. M., Howard, S. C., & Spence, J. D. (2003) · Stroke · doi:10.1161/01.str.0000094424.38761.56 · Cited by 231
Cruickshank, J. M. (1988) · BMJ · doi:10.1136/bmj.297.6658.1227 · Cited by 230
Bangalore, S., Qin, J., Sloan, S., Murphy, S. A., Cannon, C. P., & for the PROVE IT-TIMI 22 Trial Investigators (2010) · Circulation · doi:10.1161/circulationaha.109.905687 · Cited by 227
Blood Pressure and Mortality Among Men With Prior Myocardial Infarction
Flack, J. M., Neaton, J., Grimm, R., Shih, J., Cutler, J., Ensrud, K., & MacMahon, S. (1995) · Circulation · doi:10.1161/01.cir.92.9.2437 · Cited by 224
The J-curve phenomenon in stroke recurrence.
Irie, K., Yamaguchi, T., Minematsu, K., & Omae, T. (1993) · Stroke · doi:10.1161/01.str.24.12.1844 · Cited by 171
JATOS Study Group (2005) · Hypertension Research · doi:10.1291/hypres.28.513 · Cited by 143
Dorresteijn, J. A. N., van der Graaf, Y., Spiering, W., Grobbee, D. E., Bots, M. L., & Visseren, F. L. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179143 · Cited by 140
Zanchetti, A., Hansson, L., Clement, D. L., Elmfeldt, D., Julius, S., Rosenthal, T., Waeber, B., & Wedel, H. (2003) · Journal of Hypertension · doi:10.1097/00004872-200304000-00024 · Cited by 127
Cushman, W. C., Grimm, R. H., Cutler, J. A., Evans, G. W., Capes, S., Corson, M. A., Sadler, L. S., Alderman, M. H., Peterson, K., Bertoni, A., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.005 · Cited by 123
Mancia, G., Kjeldsen, S. E., Zappe, D., Holzhauer, B., Hua, T. A., Zanchetti, A., Julius, S., & Weber, M. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv633 · Cited by 109
Kovesdy, C. P., Lü, J., Molnar, M. Z., Ma, J. Z., Canada, R. B., Streja, E., Kalantar‐Zadeh, K., & Bleyer, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3279 · Cited by 95
Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
Anderson, R. J., Bahn, G. D., Moritz, T. E., Kaufman, D., Abraira, C., Duckworth, W., & for the VADT Study Group (2011) · Diabetes Care · doi:10.2337/dc10-1420 · Cited by 93
Zanchetti, A., Liu, L., Mancia, G., Parati, G., Grassi, G. M., Stramba‐Badiale, M., Silani, V., Bilo, G., Corrao, G., Zambon, A., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000254 · Cited by 75
Cardiac remodeling in systemic hypertension
Kenchaiah, S., & Pfeffer, M. A. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00168-8 · Cited by 74
Impact of lower achieved blood pressure on outcomes in hypertensive patients
Okin, P. M., Hille, D. A., Kjeldsen, S. E., Dahlöf, B., & Devereux, R. B. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283516499 · Cited by 72
Blood Pressure, Dementia and Alzheimer’s Disease: The OPTIMA Longitudinal Study
Razay, G., Williams, J. H., King, E. M., Smith, A. D., & Wilcock, G. K. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000230877 · Cited by 60
Lee, D. S., Ghosh, N., Floras, J. S., Newton, G. E., Austin, P. C., Wang, X., Liu, P. P., Stukel, T. A., & Tu, J. V. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.869743 · Cited by 58
Sundström, J., Sheikhi, R., Östgren, C. J., Svennblad, B., Bodegård, J., Nilsson, P. M., & Johansson, G. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836123aa · Cited by 41
Sheng, C., Liu, M., Zou, J., Huang, Q., Li, Y., & Wang, J. (2012) · Blood Pressure · doi:10.3109/08037051.2012.748998 · Cited by 8
Self-citation
Research works printed but not linked: 2
- 10.1001/jama.1970.03170330025003 · DOI · Paper page
- 10.1097/00004872-199410000-00009 · doi:10.1097/00004872-199410000-00009
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Metadata
- Authors
- Kang, Y.-Y., & Wang, J.-G.
- Venue
- Pulse
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 2074-1855 (ISSN-L)
- 2235-8676
- 2235-8668
- OpenAlex
- W2437822687
- Cited by
- 1,530
- References
- 67
- FWCI
- 148.91
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.